News

Filter
99 found
Midwife Amichia Solange & Angelica Konate outside their health centre in Cote d'Ivoire

WHO gives ‘strong recommendation’ supporting use of antimalarial drug to treat pregnant women in the first trimester

28 Nov 2022

MMV awards Project of the Year 2021 to GSK for the discovery of GSK484

12 Jul 2022

MMV’s CSO Dr Timothy Wells awarded honorary degree from University of Dundee

23 Jun 2022

Professor Michael Ferguson receives British Society for Parasitology Honorary Membership

04 Mar 2022

MMV launches innovative drug research tool

01 Dec 2021

MMV devises a predictive tool to assess resistance to antimalarial compounds and guide their development

31 May 2021

MMV awards Project of the Year 2020 to Professor David Fidock and team for critical contribution to malaria drug resistance profiling

18 Dec 2020

Despite early indicators of artemisinin resistance in Rwanda, ACTs continue to cure malaria

19 Aug 2020

MMV awards Project of the Year 2019 to Novartis for the discovery of INE963

13 Jul 2020

MMV launches Malaria Libre, a new open source drug discovery programme

07 Jul 2020

ESAC member Sir Simon Campbell inducted into the RSC-BMCS Hall of Fame

30 Jun 2020

MMV’s Dr James Duffy appointed to RSC Lectureship

19 Jun 2020

Via Grand Challenges Africa, MMV supports eight African drug discovery scientists

23 Sep 2019

MMV awards its Project of the Year 2018 to University of Dundee researchers

10 Jul 2019

Prof Jonathan Vennerstrom receives prestigious ACS Award for Creative Invention

24 Apr 2019

Professor Michael Ferguson receives Knighthood in New Year’s Honours List

14 Jan 2019

Open source effort identifies hundreds of compounds that could protect vulnerable populations from malaria

07 Dec 2018

Access to Medicines Index highlights role of collaboration in stimulating R&D

21 Nov 2018

MMV Project of the Year 2017 awarded to Sanofi

10 Jul 2018

MMV partner Kelly Chibale in Fortune Greatest Leaders list 2018

30 Apr 2018

Major study confirms tolerability and high efficacy of 4 gold-standard malaria medicines, when used for repeated treatment over a 2 year period

29 Mar 2018

PLOS Medicine publishes New Malaria Eradication Road Map

01 Dec 2017

Two new MMV-supported research sites inaugurated in Ethiopia

30 Nov 2017

Two MMV partners receive international award

30 Nov 2017

MMV backs training course for study coordinators

01 Nov 2017

MMV hosts international drug discovery meeting in Geneva

26 Oct 2017

Three vivax research teams awarded MMV Project of the Year 2016

10 Oct 2017

MMV discovery partners receive ASBMB awards

09 Oct 2017

Everything you always wanted to know about malaria and more

03 Aug 2017

New publication highlights efficacy of MMV048 against resistant strains of malaria

27 Apr 2017

New antimalarial compound treats and protects in a single dose

29 Mar 2017

MMV partner Prof. David Fidock wins the 2016 Advance Global Australian of the Year Award in Life Sciences

21 Oct 2016

First open source malaria publication describes new way to do drug discovery

14 Sep 2016

PLOS Pathogens publishes the Malaria Box findings

28 Jul 2016

MMV awards seven endemic-region scientists Challenge Grants to ‘exploit the Pathogen Box’

25 Jul 2016

Endemic-Region Challenge Grants of USD 50,000 each available to exploit the Pathogen Box

31 Mar 2016

MMV launches the Pathogen Box

14 Dec 2015
European regulators grant Pyramax® a revised label

European regulators grant Pyramax® a revised label

20 Nov 2015

WHO awards over $1 million to MMV’s ‘Exploiting the Pathogen Box’ project

19 Aug 2015

Pre-clinical assessment of exciting new malaria drug candidate published

16 Jul 2015

OZ439 recognized as a high-impact innovation to transform global health

16 Jul 2015

MMV wins Tim Berners-Lee’s Open Data Innovation Award

10 Jul 2015

MMV awards challenge grants to seven Malaria Box recipients

06 Mar 2015

First Chair of MMV’s ESAC receives knighthood

12 Jan 2015

Three new roads leading to a common pathway

09 Dec 2014

MMV partner Prof. Luiz Carlos Dias receives Santander University Award

13 Nov 2014

MMV organizes international malaria conference in Berlin

01 Jul 2014

MMV and Merck Serono join forces in antimalarial drug discovery

24 Feb 2014

MMV and partners call for compounds to fill the Pathogen Box

18 Feb 2014

Tafenoquine successfully completes Phase IIb clinical trials

19 Dec 2013

State-of-the-art laboratory to study new antimalarials opens in Jakarta

10 Dec 2013

New antimalarial drug target identified

29 Nov 2013

Partners commit to bolstering open source research

27 Nov 2013

MMV signs MoU with Takeda and GHIT (Japan)

11 Nov 2013

MMV partner receives PLOS Accelerating Science Award

23 Oct 2013

First-ever drug compound developed on African soil, an antimalarial, to move to human trials

08 Oct 2013

MMV’s ‘Challenge Model’ creates a buzz in Australia

16 Sep 2013

Potential new class of antimalarials now open source

10 Sep 2013

African research is rising

12 Jul 2013

Quinolones: breathing new life into an old class of compounds to tackle malaria

20 Mar 2013

Pages